Literatura académica sobre el tema "ANTIHISTAMINE DRUGS"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "ANTIHISTAMINE DRUGS".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "ANTIHISTAMINE DRUGS"
Maeda, Toshiki, Akira Babazono y Takumi Nishi. "Surveillance of First-Generation H1-Antihistamine Use for Older Patients with Dementia in Japan: A Retrospective Cohort Study". Current Gerontology and Geriatrics Research 2018 (2 de julio de 2018): 1–6. http://dx.doi.org/10.1155/2018/3406210.
Texto completoOyekan, P. J., H. C. Gorton y C. S. Copeland. "Over-the-counter antihistamines in drug-related deaths: a population-based case series". International Journal of Pharmacy Practice 29, Supplement_1 (26 de marzo de 2021): i30—i31. http://dx.doi.org/10.1093/ijpp/riab015.037.
Texto completoShabanov, D. V. y Ju E. Lutkovskaya. "Actual antihistamine therapy". Meditsinskiy sovet = Medical Council, n.º 16 (14 de noviembre de 2020): 26–35. http://dx.doi.org/10.21518/2079-701x-2020-16-26-35.
Texto completoVuković, Milana, Dunja Vesković, Nemanja Todorović, Tatjana Roš, Jasmina Jovanović-Ljubičić, Danilo Kuzman, Mladena Lalić-Popović, Dejan Miljković y Boris Milijašević. "Comparative analysis of the consumption of antihistamines for systemic use in the Republic of Serbia and Nordic countries in the period 2009-2019". Hospital Pharmacology - International Multidisciplinary Journal 10, n.º 1 (2023): 1250–63. http://dx.doi.org/10.5937/hpimj2301250v.
Texto completoCho, Kyoo H., Ji E. Lee, Sook K. Song y Phil Hyu Lee. "Chorea induced by antihistamine drugs". Movement Disorders 25, n.º 4 (27 de enero de 2010): 519–20. http://dx.doi.org/10.1002/mds.22965.
Texto completoKareva, E. N. "Pharmacological optimization of antihistamine profile". Russian Medical Inquiry 6, n.º 2 (2022): 92–97. http://dx.doi.org/10.32364/2587-6821-2022-6-2-92-97.
Texto completoTsarev, S. V. "Antihistamine therapy in pediatric practice". Medical Council, n.º 11 (16 de julio de 2018): 136–39. http://dx.doi.org/10.21518/2079-701x-2018-11-136-139.
Texto completoStahl, Stephen M. "Selective Histamine H1 Antagonism: Novel Hypnotic and Pharmacologic Actions Challenge Classical Notions of Antihistamines". CNS Spectrums 13, n.º 12 (diciembre de 2008): 1027–38. http://dx.doi.org/10.1017/s1092852900017089.
Texto completoLisni, Ida, Ani Anggriani y Regina Puspitasari. "KAJIAN PERESEPAN OBAT ANTIHISTAMIN PADA PASIEN RAWAT JALAN DI SALAH SATU RUMAH SAKIT DI BANDUNG". Jurnal Riset Kefarmasian Indonesia 2, n.º 2 (1 de mayo de 2020): 52–62. http://dx.doi.org/10.33759/jrki.v2i2.77.
Texto completoAssadi, Sara, Latif Rahman, Mark Kong y Sukaina Asad. "Could the Use of Antihistamines Have Triggered Reversible Cerebral Vasoconstriction Syndrome? A Case Report". Case Reports in Acute Medicine 4, n.º 2 (28 de junio de 2021): 50–57. http://dx.doi.org/10.1159/000517115.
Texto completoTesis sobre el tema "ANTIHISTAMINE DRUGS"
Baxter, R. I. "Voltammetric studies of some important antihistamine drugs". Thesis, Queen's University Belfast, 1985. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.374204.
Texto completoShamsi, Ziba. "Measurement of drug action in man : psychometric aspects of antihistamines". Thesis, University of Surrey, 1999. http://epubs.surrey.ac.uk/843065/.
Texto completoSchooley, Elizabeth K. "The effects of an antiseritonergic drug and antihistamine in an experimental model of feline asthma". Diss., Columbia, Mo. : University of Missouri-Columbia, 2007. http://hdl.handle.net/10355/5033.
Texto completoThe entire dissertation/thesis text is included in the research.pdf file; the official abstract appears in the short.pdf file (which also appears in the research.pdf); a non-technical general description, or public abstract, appears in the public.pdf file. Vita. "May 2007" Includes bibliographical references.
Mousa, Aisha H. "Characterization of a novel histamine G protein-coupled receptor from Schistosoma mansoni (SmGPCR)". Thesis, McGill University, 2002. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=79055.
Texto completoFernandes, João Paulo dos Santos. "Planejamento e sintese de compostos potencialmente ligantes dos receptores 5-HT2C e H4". Universidade de São Paulo, 2012. http://www.teses.usp.br/teses/disponiveis/9/9138/tde-18022013-135502/.
Texto completoSerotonin and histamine are two major biogenic amines in the body. They regulate several physiological functions such as blood flow, body temperature, sleep, hunger, hormone release, emotional behavior and mood, among others. Thus, there is great interest in the design and development of drugs that interfere with serotoninergic and histaminergic transmission, for future use as antidepressants, antipsychotics, anxiolytics and anorectic, and peripherally, possible anti-inflammatory actions. The aim of this work is to present the synthesis of compounds containing the pyrroloquinoline, benzoindole and benzodihydrofurane nucleus with potential binding activity to 5-HT2C and H4 receptors, as well as to evaluate the selectivity of these compounds in comparison to 5-HT2A/B and H3. Series of compounds were synthesized using allylation, carbonyl addition, thermal cyclization, Claisen rearrangement, iodocyclization and nucleophilic substitution reactions. Optimization studies for the synthesis using response surface methodology are also presented, as well as quantitative structure-activity relationships studies of ligands of 5-HT2C and H4 receptors.
Ciurlizza, Celis Claudia Paola. "Aportación al estudio de permeación transdérmica de cetirizina". Doctoral thesis, Universitat de Barcelona, 2017. http://hdl.handle.net/10803/457668.
Texto completoWu, Jia-Syuan y 吳佳璇. "Analyzing the Allergic Reactions Induced by the Chemotherapy Regimens Including Oxaliplatin and Evaluating the Effectiveness of Receiving Preventive Antihistamine Drugs". Thesis, 2014. http://ndltd.ncl.edu.tw/handle/66498648402200227481.
Texto completo高雄醫學大學
藥學研究所碩士在職專班
102
【Background】 According to the latest 2011 cancer registration report announced by Taiwan Health Promotion Administration, Ministry of Health and Welfare, the incidence of gastric cancer is ranked No. 6 in males and No. 8 in females, while the incidence of colorectal cancer ranked No. 1 in males and ranked No. 2 in females. Oxaliplatin is currently one of the main drugs of chemotherapy for colorectal cancer and end-stage gastric cancer. Oxaliplatin is a third- generation platinum compound, which is approved by the National Health Insurance Bureau for treatment of stage III colon-rectal cancer, metastatic colorectal cancer and partially end-stage or metastatic gastric cancer. According to many studies, about 90% of the patients who have received oxaliplatin treatments are accompanied by peripheral neuropathy, whose grade is related to the dosage of oxaliplatin. Most of these adverse events can recover during the chemotherapy cycles. The clinical medical staff can provide patients with instructions to against these adverse drug reactions. However, registered allergic reactions as another adverse drug reaction of oxaliplatin, besides neuropathy, are increasing in recent years, severe allergic reactions even interrupted ongoing oxaliplatin treatments because some of the patients came to the end of endurance. Objective : During the clinical treatment, patients are given antihistamine drugs to alleviate allergic reactions induced by oxaliplatin, and it is successful in most of them. Due to the effect, some clinical doctors give the patients antihistamine drugs in advance to prevent allergic reactions before the patients receive oxaliplatin infusions. However, on the one side, antihistamine drugs often cause dizziness, nausea, or conscious disturbance. On the other side, the antihistamine drugs cannot prevent some patients effectively from oxaliplatin-induced allergic reactions by clinical observation. Because there is no relevant guideline for the prevention from oxaliplatin-induced allergic reactions, this study aims to evaluate the effectiveness of the prevention of antihistamine drugs against oxaliplatin-induced allergic reactions in order to provide information on clinical treatment and post-treatment care. 【Methods】 This is a retrospective case-control study with subjects composed of patients who have allergic reactions after receiving oxaliplatin infusions from January 2008 to May 2013 in a medical center in southern Taiwan. The subjects are divided into two groups: the study group consisted of patients without taking antihistamine drugs before the oxaliplatin infusion; the control group consisted of patients taking antihistamine drugs before the oxaliplatin infusions. By means of case review and combining with the adverse drug reaction registration system in the hospital, we analyze the incidence of oxaliplatin-induced allergic reactions and the grade of allergic reactions. The data are processed and analyzed by SPSS 19.0 for Windows and explained with descriptive statistics of percentage, mean value, median value and standard deviation, as well as inferential statistics of Chi-Square test and 95% confidence interval analysis. 【Results】 There were 545 patients receiving oxaliplatin infusions from January 2008 to May 2013. Finally 535 patients are included for analysis, including 85 patients (15.6%) reported with allergic reactions, which occurred after a median of the eighth infusion of oxaliplatin. 61 patients of them received oxaliplatin re-challenge; 46 of these 61 patients (75.4%) led to further reactions, and 24 patients (28.2%) stopped their oxaliplatin treatment owing to intolerance to oxaliplatin-induced allergic reactions. The symptoms of oxaliplatin-induced allergic reactions are primarily skin rashes (76.5%), secondly shortness of breath and chest tightness (32.3%), sweating, vomiting and so on. These 535 patients receiving oxaliplatin infusions were divided into two groups, 164 patients without receiving antihistamine drugs before the oxaliplatin infusion in the study group, and 371 patients receiving antihistamine drugs before the oxaliplatin infusion in the control group. 27 patients (16.46%) in the study group had allergic reactions, while allergic reactions happened to 58 patients (15.22%) in the control group. The rates of oxaliplatin-induced allergic reactions show no statistically significant difference (P> 0.05) between the two groups, revealing that receiving antihistamine drugs before the oxaliplatin infusion cannot effectively prevent allergic reactions. 【Conclusion】 This study reveals that the effectiveness of giving patients in the study group antihistamine drugs to prevent allergic reactions caused by oxaliplatin had no statistically significant difference from that in the control group. It was also found that giving antihistamine drugs in advance not only increases side effects such as dizziness, nausea and conscious disturbance but also could not effectively prevent allergic reactions caused by oxaliplatin. The findings provide information for clinical treatments that giving antihistamine drugs after allergic reactions occur due to oxaliplatin instead of giving it in advance for prevention not only reduces the complexity of the clinical implementation and adverse reactions caused by antihistamine drugs but also helps increase cost-effectiveness in all the aspects of medical treatment. Clinically, patient instructions about patient’s awareness of allergic reactions and self-care abilities, besides the often seen gastrointestinal side effects and neuropathy, should be enhanced, especially for the patients who have had allergic symptoms due to oxaliplatin and to more than 70% of whom it happens again after oxaliplatin re-challenge. Other preventive methods such as extending the time of oxaliplatin infusions or decreasing oxaliplatin dosage to reduce allergic reactions need more researches to verify their effectiveness.
Kiszkiel-Taudul, Ilona. "Ekstrakcyjne metody wydzielania wybranych leków przeciwhistaminowych i ich analiza w próbkach środowiskowych". Phd thesis, 2016. http://hdl.handle.net/11320/4826.
Texto completoThe presence of biologically active compounds in the environment harmfully influences for human health and aquatic organisms. Therefore, the elaborating of the extraction procedures to assure detection of pharmaceuticals with high sensitivity and selectivity is significant. The new extraction methods for isolation of antihistaminic drugs (cimetidine, nizatidine, ranitidine and famotidine) from water samples were elaborated. The used procedures were not yet applied for separation of these compounds. The extraction and separation process of analytes was performed with using solid phase extraction (SPE), micellar extraction (ME) and ultrasound assisted extraction (UAE). The extracts were analyzed by using the spectrophotometric and chromatographic methods with different kind of detection. Miniaturized techniques: dispersive liquid-liquid microextraction (DLLME), ultrasound assisted emulsification microextraction (USAEME), single drop microextraction (SDME) and ionic liquids as extractants were used for isolation of the analytes. Developed methods allow for their preconcentration and decreasing of limit of detection. The SPE procedure for simultaneous isolation of compounds connected with chromatographic separation by using LC-MS/MS method was also elaborated. Developed procedures were used for determination of analytes in natural water samples and pharmaceutical preparations.
Wydział Biologiczno-Chemiczny. Instytut Chemii.
Magalhães, Gilberto Teixeira. "Intoxicações agudas por medicamentos de uso comum em pediatria". Master's thesis, 2021. http://hdl.handle.net/10284/10867.
Texto completoDrug poisoning, whether internationally or not internationally, is an important factor of mortality and morbidity among children, often requiring hospitalization. The identification of the toxic agent, through the set of signs and symptoms, as well as the exposure history, is essential to start the treatment/decontamination, as soon as possible, in order to reduce hospitalization time and health complications. The treatment of intoxication is different according the compound and involves symptomatic treatment, decontamination measures and increased elimination of the toxicant. This dissertation aims to carry out a narrative review of the drugs, or pharmacotherapeutic groups most reported poisoning cases in pediatric age, highlighting, in each case, the new therapeutic approaches, some of which still in the clinical phases.
Libros sobre el tema "ANTIHISTAMINE DRUGS"
1952-, Schlegel Robert E., Nesthus Thomas E, United States. Office of Aviation Medicine., University of Oklahoma. Dept. of Psychology., University of Oklahoma. School of Industrial Engineering. y Civil Aeromedical Institute, eds. Effects of antihistamine, age, and gender on task performance. Washington, D.C: U.S. Dept. of Transportation, Federal Aviation Administration, Office of Aviation Medicine, 1999.
Buscar texto completoR, Simons F. E., ed. Histamine and H1-antihistamines in allergic disease. 2a ed. New York: Marcel Dekker, 2002.
Buscar texto completo(Canada), Expert Advisory Committee on Nonprescription Cough and Cold Remedies. First report. Ottawa: National Health and Welfare Canada, 1988.
Buscar texto completoZemskov, Vladimir y Veronika Zemskova. Immunotropic effects of therapeutic factors. ru: INFRA-M Academic Publishing LLC., 2020. http://dx.doi.org/10.12737/1039485.
Texto completoNiels, Mygind y Naclerio Robert M. 1950-, eds. Rhinoconjunctivitis: New perspectives in topical treatment. Toronto: Hogrefe & Huber, 1989.
Buscar texto completoDivya, Vohora, ed. The third histamine receptor: Selective ligands as potential therapeutic agents in CNS disorders. Boca Raton: CRC Press, 2009.
Buscar texto completoR, Simons F. E., ed. Histamine and H1-receptor antagonists in allergic disease. New York: M. Dekker, 1996.
Buscar texto completoBaxter, Robert Ivan. Voltammetric studies of some important antihistamine drugs. 1985.
Buscar texto completoSimons, F. Estelle R. Histamine and H1-Antihistamines in Allergic Disease, Second Edition, (Clinical Allergy and Immunology). 2a ed. Informa Healthcare, 2002.
Buscar texto completoThe U.S. market for over-the-counter cough, cold, allergy and sinus products. New York, N.Y: Kalorama Information, 2005.
Buscar texto completoCapítulos de libros sobre el tema "ANTIHISTAMINE DRUGS"
Källén, Bengt. "Maternal Use of Antihistamine Drugs for Allergy and Infant Congenital Malformations". En Maternal Drug Use and Infant Congenital Malformations, 383–88. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-17898-7_34.
Texto completoLittle, “Bert” Bertis Britt. "Antihistamines, Decongestants, and Expectorants during Pregnancy". En Drugs and Pregnancy, 231–40. 2a ed. Boca Raton: CRC Press, 2022. http://dx.doi.org/10.1201/9780429160929-11.
Texto completoDe Vos, C. y J. P. Rihoux. "H1-Antihistamines". En New Drugs for Asthma, Allergy and COPD, 128–32. Basel: KARGER, 2001. http://dx.doi.org/10.1159/000062147.
Texto completoSaxena, Anil K. y Mridula Saxena. "Developments in antihistamines (H1)". En Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques, 35–125. Basel: Birkhäuser Basel, 1992. http://dx.doi.org/10.1007/978-3-0348-7144-0_3.
Texto completoSoldatos, C. R. y D. G. Dikeos. "Neuroleptics, Antihistamines and Antiparkinsonian Drugs: Effects on Sleep". En Handbook of Experimental Pharmacology, 443–64. Berlin, Heidelberg: Springer Berlin Heidelberg, 1995. http://dx.doi.org/10.1007/978-3-642-57836-6_16.
Texto completoFukui, Hiroyuki, Hiroyuki Mizuguchi, Hisao Nemoto, Yoshiaki Kitamura, Yoshiki Kashiwada y Noriaki Takeda. "Histamine H1 Receptor Gene Expression and Drug Action of Antihistamines". En Handbook of Experimental Pharmacology, 161–69. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/164_2016_14.
Texto completoCrowe, Andrew. "Case Studies of Non-CNS Drugs to Minimize Brain Penetration-Nonsedative Antihistamines". En Blood-Brain Barrier in Drug Discovery, 463–81. Hoboken, NJ: John Wiley & Sons, Inc, 2015. http://dx.doi.org/10.1002/9781118788523.ch21.
Texto completoVirginia Soldovieri, Maria y Maurizio Taglialatela. "Cellular Mechanisms, Molecular Targets, and Structure-Function Relationships in Drug-Induced Arrhythmias: Antihistamines, Psychoactive Drugs, and Antimicrobial Agents". En Cardiotoxicity of Non-Cardiovascular Drugs, 47–96. Chichester, UK: John Wiley & Sons, Ltd, 2010. http://dx.doi.org/10.1002/9780470660379.ch3.
Texto completoFukui, Hiroyuki, Hiroyuki Mizuguchi, Yoshiaki Kitamura y Noriaki Takeda. "Clinical Significance of Histamine H1 Receptor Gene Expression and Drug Action of Antihistamines". En Histamine Receptors, 157–72. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-40308-3_6.
Texto completoVardanyan, Ruben y Victor Hruby. "Antihistamine Drugs". En Synthesis of Best-Seller Drugs, 247–63. Elsevier, 2016. http://dx.doi.org/10.1016/b978-0-12-411492-0.00016-x.
Texto completoInformes sobre el tema "ANTIHISTAMINE DRUGS"
Schiflett, Samuel G. Antihistamine Drugs and Performance on C3 Tasks. Fort Belvoir, VA: Defense Technical Information Center, febrero de 1992. http://dx.doi.org/10.21236/ada250762.
Texto completo